ANIK vs SCHW · rev $62.2M vs P/E 19, rev $13.55B
Anika Therapeutics Inc (ANIK) versus Charles Schwab Corp (SCHW) — a side-by-side from cached financials, not a winner call.
Anika Therapeutics Inc (ANIK) is a drug manufacturers - specialty & generic company listed on US.
Charles Schwab Corp (SCHW) is a capital markets company listed on NYSE. It is led by Richard Andrew Wurster C.F.A., CMT.
Latest reported ANIK revenue for 2026-06-30 was $62.2M. Net income was -$1.7M. ANIK currently screens at market cap $161.3M.
Latest reported SCHW revenue for 2026-06-30 was $13.55B. Net income was $5.28B. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
ANIK currently screens at market cap $161.3M. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
Not investment advice. Open the ANIK and SCHW stock pages for the full models.
Not investment advice.